Basic Neuroscience Division, Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts.
Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Biol Psychiatry. 2021 Jun 15;89(12):1138-1149. doi: 10.1016/j.biopsych.2020.12.030. Epub 2021 Jan 13.
Stress is implicated in the pathophysiology of major depression and posttraumatic stress disorder. These conditions share core features, including motivational deficits, heighted anxiety, and sleep dysregulation. Chronic stress produces these same features in rodents, with some individuals being susceptible or resilient, as seen in humans. While stress-induced neuroadaptations within the nucleus accumbens are implicated in susceptibility-related dysregulation of motivational and emotional behaviors, their effects on sleep are unclear.
We used chemogenetics (DREADDs [designer receptors exclusively activated by designer drugs]) to examine the effects of selective alterations in activity of nucleus accumbens medium spiny neurons expressing dopamine D receptors (D1-MSNs) or dopamine D receptors (D2-MSNs) on sleep-related end points. Mice were implanted with wireless transmitters enabling continuous collection of data to quantify vigilance states over a 20-day test period. Parallel cohorts were examined in behavioral tests assessing stress susceptibility.
D1- and D2-MSNs play dissociable roles in sleep regulation. Stimulation of inhibitory or excitatory DREADDs expressed in D1-MSNs exclusively affects rapid eye movement sleep, whereas targeting D2-MSNs affects slow wave sleep. The combined effects of D1-MSN inhibition and D2-MSN activation on sleep resemble those of chronic social defeat stress. Alterations in D1-MSN function also affect stress susceptibility in social behavior tests. Elevation of CREB (cAMP response element-binding protein) within D1-MSNs is sufficient to produce stress-like effects on rapid eye movement sleep.
In addition to regulation of motivational and emotional behaviors, the nucleus accumbens also influences sleep, an end point with high translational relevance. These findings provide a neural basis for comorbidity in key features of stress-related illness.
压力与重度抑郁症和创伤后应激障碍的病理生理学有关。这些病症具有核心特征,包括动机缺陷、焦虑加剧和睡眠失调。慢性压力会在啮齿动物中产生这些相同的特征,一些个体易受影响或具有弹性,这与人类相似。虽然伏隔核内的应激诱导神经适应性变化与动机和情绪行为的易感性相关失调有关,但它们对睡眠的影响尚不清楚。
我们使用化学遗传学(DREADD [专门被设计药物激活的设计受体])来检查表达多巴胺 D 受体(D1-MSNs)或多巴胺 D 受体(D2-MSNs)的伏隔核中间神经元活性选择性改变对睡眠相关终点的影响。小鼠植入了无线发射器,可在 20 天的测试期内连续收集数据以量化警觉状态。平行队列被用于评估应激易感性的行为测试中进行了检查。
D1-MSNs 和 D2-MSNs 在睡眠调节中发挥可分离的作用。在 D1-MSNs 中表达的抑制性或兴奋性 DREADD 的刺激仅影响快速眼动睡眠,而靶向 D2-MSNs 则影响慢波睡眠。D1-MSN 抑制和 D2-MSN 激活对睡眠的综合影响类似于慢性社交挫败应激的影响。D1-MSN 功能的改变也会影响社交行为测试中的应激易感性。D1-MSN 内 CREB(cAMP 反应元件结合蛋白)的升高足以对快速眼动睡眠产生应激样影响。
除了调节动机和情绪行为外,伏隔核还会影响睡眠,这是一个具有高度转化相关性的终点。这些发现为应激相关疾病的关键特征的共病提供了神经基础。